Medical experts say that we are no closer to getting Kovid-19

A person is taking a selfie in a room: a lab technician wearing a full body protection suit, one on August 6, 2020, at Vulneva SA Laboratories in Vienna, Austria on Thursday, during a coronovirus vaccine research containing growth media for virus production Inspects the bottle.  : Akos Stiller / Bloomberg via Getty Image

© Akos Stiller / Bloomberg via Garter Images
A lab technician, wearing a full body protection suit, inspects a bottle containing growth media for virus production during coronovirus vaccine research on Thursday August 6, 2020 at the Vallneva SA laboratories in Vienna, Austria.

First, good news: In 24 states, the number of new coronovirus cases decreased last week compared to the previous week.

Now, the bad news: In many of those states, testing has also decreased. And the total number of new cases daily is still very high as America faces major challenges this fall.

“The decline is not really looking very good,” epidemiologist Drs. Said Celine Gounder.

On Sunday, 34,450 new cases were reported across the country, according to Johns Hopkins University data. This is better than the previous two weeks in July, when there were over 60,000 new cases in the US every day.

According to data from the Kovid Tracking Project, nationwide testing is down 10% this year compared to last week.

Health experts reported on Monday that of the confirmed cases, 34,450 is still a large number.

Michael Osterholm, director of the Center for Infectious Diseases Research and Policy, said, “We never had a reduction in cases. Remember, we’re talking about 35,000 cases a day. Today, we’re over 40,000 cases per day Is likely to hit. ” At the University of Minnesota.

“Back in April … we had 22,000 cases a day and thought, ‘My God, it couldn’t be any worse.” And what is happening here we are going to see such ups and downs, ups and downs. But each time it goes up, it is slightly higher. Every time it comes down, it doesn’t. all the way down. ”

Track the virus in your state and nationwide

According to Johns Hopkins data, as of Monday afternoon, more than 6.5 million people have been infected with coronovirus in the US and more than 194,000 have died.

3 big challenges

Epidemiologists say that America should get the virus under control because the US will soon face many challenges simultaneously:

Upcoming Flu Season: The imminent flu season with a coronovirus epidemic may reduce or exceed hospital capacity, as hundreds of Americans are hospitalized with flu each year.

And having one of the two viruses can make you more vulnerable to being infected by the other.

“You’re going to have all these patients come to hospitals and doctors’ office with symptoms that could be coronovirus, which could be the flu,” Gounder said.

“And we’re going to treat them all like they have coronovirus. So it’s a very dangerous and scary situation to be.”

Cold Weather: If more people gather indoors, the risk of viral outbreaks is higher than in outdoor ceremonies, doctors say.

Academic conflict: While millions of students struggle with online learning, many schools that bring students back to classrooms suffer from the outbreak.

Mayor Kelly Geertz said Athens-Clarke County, Georgia – is home to the University of Georgia, where cases have seen a “dramatic spike” after maintaining the entire case count and death toll.

“Clearly, this is a return to the campus of a large number of students who are not here during the summer,” the mayor said.

Mayor of East Lansing Aaron Stephens said students at Michigan State University were asked to quarantine by the local health department since August 24 after 342 new cases were reported among people associated with the university.

Some good news on the vaccine front

However, experts believe that the Kovid-19 vaccine may not be publicly available until 2021, but phase 3 trials currently have some promising indications of several vaccines.

Pfizer CEO Albert Borla told CBS’s “Face the Nation” that by the end of October, researchers would find out whether the “experimental vaccine works”.

“Then, of course, it’s (a) the regulator’s job to issue (or not) a license,” Borla said.

The University of Oxford announced that its trial would resume after one of the volunteers in the United Kingdom stopped due to unexplained illness. Experts say that stopping tests is not uncommon.

And vaccine makers are reporting progress with the recruitment of minority trial participants, which has been a struggle in recent weeks.

“We feel that we should strive for a more diverse population,” Borla told CBS, stressing the importance of a diverse group of volunteers, saying that the Kovid-19 has had a color on communities.

“We are not bad right now. In fact, we have a population that only 60% globally are Caucasian, 40%, almost, are minorities.”

Modern, which is also in Phase 3 testing of the vaccine, said its minority enrollment has also improved. About 59% of the participants are white, 22% are Hispanic, 11% are black, 5% are Asian, and 3% are from other populations.

Video: This may be your most important flu vaccine (CNN)

This may be your most important flu vaccine ever



Continue reading